• linkedin
  • Increase Font
  • Sharebar

    3 compliance rules pharmacies must know

    With 2016 well underway, pharmacies of all sizes should review recent regulatory updates to ensure compliance with rules already in effect, and preparation for those to be implemented soon. Three, in particular, warrant a close look.

    Ken MaxikUSP 797 Pharmaceutical Compounding – Sterile Preparations. The comment period for USP’s proposed revisions for compounding sterile preparations closed January 2016, and comments are now under review. If finalized as-is, USP 797 may publish by November 2016, at which time pharmacies will face significant changes, including:

    • A more inclusive compounding definition requiring master formulation and compounding records for all batch and non-sterile compounding activities.

    • A new term (in-use time) defining the time before which a manufactured product or compounded dilution bag must be utilized after it has been punctured.

    • More environmental control requirements, including monthly viable air and surface sampling.

    • Increased accountability for staff competency with visual observation of hand hygiene and garbing, and quarterly media fill and fingertip testing.

     In October 2015, CMS incorporated USP 797 into its requirements for participation in Medicare and Medicaid programs, forerunning more stringent review by CMS and regulatory bodies related to pharmacy compliance with this chapter.

    Kenneth Maxik
    Kenneth Maxik – director of patient safety and compliance for CompleteRx – has worked with hospitals for more than 20 years on a range ...

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available